2023
DOI: 10.3390/vaccines11071179
|View full text |Cite
|
Sign up to set email alerts
|

A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus

Abstract: The 2022 global outbreaks of monkeypox virus (MPXV) and increased human-to-human transmission calls for the urgent development of countermeasures to protect people who cannot benefit from vaccination. Here, we describe the development of glycovariants of 7D11, a neutralizing monoclonal IgG antibody (mAb) directed against the L1 transmembrane protein of the related vaccinia virus, in a plant-based system as a potential therapeutic against the current MPVX outbreak. Our results indicated that 7D11 mAb quickly ac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…Agroinfiltration was used extensively over the last decade for the transient expression of recombinant proteins in N. benthamiana . This applies also to mAbs, especially to IgG1, with large variation in expression levels ( Shanmugaraj et al, 2020 ; Chen, 2022 ; Esqueda et al, 2023 ). Comparably moderate levels were obtained by transient expression of other Ab isotypes and subtypes, like IgM and IgG3 ( Loos et al, 2014 ; Kallolimath et al, 2020 ; Kallolimath et al, 2021 ; Sun et al, 2021 ; Kallolimath et al, 2023 ).…”
Section: Resultsmentioning
confidence: 99%
“…Agroinfiltration was used extensively over the last decade for the transient expression of recombinant proteins in N. benthamiana . This applies also to mAbs, especially to IgG1, with large variation in expression levels ( Shanmugaraj et al, 2020 ; Chen, 2022 ; Esqueda et al, 2023 ). Comparably moderate levels were obtained by transient expression of other Ab isotypes and subtypes, like IgM and IgG3 ( Loos et al, 2014 ; Kallolimath et al, 2020 ; Kallolimath et al, 2021 ; Sun et al, 2021 ; Kallolimath et al, 2023 ).…”
Section: Resultsmentioning
confidence: 99%